163
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Biological Evaluation and Molecular Docking Study of Euparin and Its Maleic Anhydride and Semicarbazide Derivatives

, ORCID Icon, , &
Pages 409-420 | Received 29 Jul 2021, Accepted 26 Nov 2021, Published online: 15 Dec 2021
 

Abstract

Euparin (1) as a natural product was derivatized by maleic anhydride (2), semicarbazide (3), phenylacetic acid (4 and 5), and thiosemicarbazide (6) and their activities were evaluated in silico by molecular docking studies to investigate the binding affinities and interaction modes between the samples and N-myristoyltransferase enzyme. Among the tested samples (16), compounds 13 showed significant hydrophobic and hydrogen bonding interactions with the important residues at the active site of the receptor. Therefore, the biological properties of compounds 13 were investigated in this work. The antifungal activity of compounds 13 was tested against Candida albicans. Amongst them, euparin 1 with minimum inhibitory concentration (MIC) of 7.81 µg/mL and minimum fungicidal concentration (MFC) of 15.62 µg/mL exhibited the highest antifungal activity. Furthermore, antibacterial activities were studied against two Gram-positive (Staphylococcus aureus and Bacillus subtilis), and two Gram-negative (Escherichia coli and Pseudomonas aeruginosa) bacteria, the highest zone of growth on B. subtilis for compound 3 was 13.5 ± 0.7 mm, while for compound 2, the zone of growth inhibition against B. subtilis and S. aureus was 10.0 ± 1.4 and 9.5 ± 0.70 mm, respectively. Finally, the anticancer effects of 1– 3 were examined using MTT assay against MDA-MB-231 and A-549 cell lines. Compound 2 displayed cytotoxicity on MDA-MB-231 cell line with IC50 of 166 µg/mL.

Disclosure statement

The authors declare that they have no conflict of interest.

Additional information

Funding

We gratefully acknowledge financial support from the Research Council of University of Mazandaran. We would like to thankful Dr. Zahra Ghanbarimasir for her kind assistance.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.